Beta-Amyloid-Dependent miRNAs as Circulating Biomarkers in Alzheimer’s Disease: a Preliminary Report
- 18 April 2020
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 70 (6) , 871-877
Abstract
MicroRNAs (miRNAs) are considered among the most reliable biomarkers to diagnose and predict Alzheimer’s disease (AD), due to their regulatory nature. The main goal of this study was to evaluate the expression of miR4422 and miR3714, as the main regulators of GSAP and BACE1 expression, in AD patients compared with healthy subjects. Twenty patients with a mild to moderate AD (58–71 years old) and 15 healthy subjects (58–73 years old) participated in this study. The expression levels of miR4422 and miR3714 as the target genes and 5S rRNA and miRlet7a-5p as the reference genes were measured in the two groups. To compare the expression between the case and the control groups, the t test or the Wilcoxon test was used, based on the data distribution patterns. The efficiencies of amplification of the miR4422, miR3714, 5S rRNA, and miRlet7a-5p genes all were in the acceptable range. The mean miR4422-5S rRNA dCt value was significantly different between the two groups (p = 0.018). The relative fold change of the expression was 0.43. The mean miR4422-miRlet7a-5p dCt value (p = 0.41), the mean miR3714-5S rRNA dCt value (p = 0.10), and the mean miR3714-miRlet7a-5p dCt value (p = 0.063) were not significantly different between the two groups. We indicated that miR4422 could be a reliable biomarker for Alzheimer’s diagnosis. It seems that the reduced expression of miR4422 that targets GSAP and BACE1 expression can lead to an increase in the formation of Aβ plaque.Keywords
Funding Information
- Cognitive Sciences and Technologies Council (4023)
This publication has 32 references indexed in Scilit:
- miR-15b represses BACE1 expression in sporadic Alzheimer’s diseaseOncotarget, 2017
- GATA1‐mediated transcriptional regulation of the γ‐secretase activating protein increases Aβ formation in Down syndromeAnnals of Neurology, 2015
- Research status of the regulation of miRNA on BACE1International Journal of Neuroscience, 2013
- BACE1 mRNA Expression in Alzheimer's Disease Postmortem Brain TissueJournal of Alzheimer’s Disease, 2011
- GRK5 Deficiency Accelerates β-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic ActivityJournal of Biological Chemistry, 2010
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 2007
- Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein formsNeurological Sciences, 2002
- β-Amyloid, Neuronal Death and Alzheimers DiseaseCurrent Molecular Medicine, 2001